A team at Sun Yat-sen University in China has managed to use “chemical surgery” to rewrite parts of the genetic code of a human embryo. If this sounds familiar, you might be thinking of the CRISPR technique, but this is quite a bit different. Where CRISPR cuts out old code and splices in new code, […]

Media stories about Crispr Theraptc (NASDAQ:CRSP) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to […]

Welcome to the Podchaser beta! Browse around, report any bugs, and check back regularly for updates! No Ratings Dying to know the latest (and greatest) about the gene-editing super-machine, CRISPR? Well, you’re in luck. Modified tomato plants, rare cancer mapping, and addressing the world’s gluten intolerance…is there anything CRISPR can’t do? Podcast Not Enough Ratings Episode […]

In July 2017, researchers in Portland, Oregon attempted to modify a human embryo to correct defective genes that are linked to a genetic disease. This experiment was possible with CRISPR-Cas9 technology, a powerful gene editing tool that is sold online for a few hundred dollars. These experiments will grow in complexity and number as CRISPR […]

        Advertisement Trading volume for CRISPR Therapeutics AG was 284K in the last trading session. Overall, volume was up 187.56% over the stocks normal daily volume. Investors are a little more bullish on shares of the company looking at the fall in short interest. The firm had a fall in short interest from August 15, 2017 […]

Scientists are edging ever closer to being able to make minute edits to human DNA that could stop inherited medical disorders in their tracks. A team of researchers in China earlier this month published a study in the journal Protein and Cell, detailing their work editing the DNA of human embryos at a highly precise […]

CRISPR Therapeutics AG (NasdaqGM:CRSP) has an ERP5 rank of 17316. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The lower the ERP5 rank, the more undervalued a company is thought to be. The Q.i. […]

Beginning early Monday morning, Inside Science will cover the discoveries behind three of the most anticipated science prizes of the year. (Inside Science) — It’s almost time to announce the winners of the 2017 Nobel Prizes, and excitement and speculation are building. On Oct. 2, Inside Science will distribute the first of several news stories about […]

When the U.S. Food and Drug Administration issued new guidance earlier this month on how companies who handle human cells, tissues and cellular and tissue-based products should report problems to the agency, it was a recognition that the medical industry is heading deeper into uncharted territory. But FDA Commissioner Scott Gottlieb recognized that it was […]

Abstract In contrast to the well-studied condensation and folding of chromosomes during mitosis, their dynamics in interphase are less understood. We developed a sensitive, multicolor system, CRISPR-Sirius, allowing the real-time tracking of the dynamics of chromosomal loci. We tracked loci kilobases to megabases apart and found significant variation in the inter-locus distances of each pair, […]